Revenue and net profit both grew modestly year-over-year, with probiotics driving 20.85% growth and now comprising over three-quarters of total revenue. Compound food additives declined sharply, while R&D investment and cash flow improved.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.